No Data
No Data
Truist Securities Maintains Buy on PACS Group, Maintains $32 Price Target
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and maintains $32 price target.
Royal Bank of Canada: Maintaining the PACS Group (PACS.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $30.00 to $32.00.
Royal Bank of Canada: Maintaining the PACS Group (PACS.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $30.00 to $32.00.
PACS Group Is Maintained at Outperform by Oppenheimer
PACS Group Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $32
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $31 to $32.
RBC Raises Price Target on PACS Group to $32 From $30, Keeps Outperform Rating
PACS Group (PACS) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $27 to $34. Price: 26.90, Change: -0.01, Percent Change: -0.04
Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (MGX), Smith Douglas Homes Corp. Class A (SDHC) and PACS Group Inc (PACS)
No Data